글로벌 치과 수면 의학 시장 – 2031년까지의 산업 동향 및 예측

치과 수면 의학 시장 분석 및 규모

치과 수면 의학 시장은 최근 몇 년 동안 상당한 성장을 목격했는데, 이는 폐쇄성 수면 무호흡증(OSA)과 같은 수면 관련 호흡 장애에 대한 인식이 높아지고 비침습적 치료 옵션에 대한 선호도가 높아지면서 이루어졌습니다. 이 시장은 치과 개입을 통해 OSA와 기타 수면 장애를 관리하도록 설계된 다양한 구강 기구와 치료법을 포함합니다. 치과 수면 의학 솔루션에 대한 수요는 전 세계적으로 수면 무호흡증이 증가하는 것과 더 정확하고 효과적인 치료 옵션을 가능하게 하는 치과 기술의 발전과 같은 요인에 의해 촉진됩니다. 또한 치과 전문가와 수면 의학 전문의 간의 협업으로 진단 기능과 치료 결과가 향상되어 시장 확장이 더욱 촉진되었습니다. 이 분야가 지속적인 연구와 기술 혁신으로 계속 발전함에 따라 치과 수면 의학 시장은 성장 궤도를 계속 유지할 것으로 예상되며 전 세계의 제조업체, 치과 병원 및 의료 서비스 제공자에게 유망한 기회를 제공합니다.

글로벌 치과 수면제 시장 규모는 2023년에 66억 9천만 달러로 평가되었으며, 2031년까지 100억 4천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 5.21%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

Market Definition

Dental sleep medicine is a specialized field within dentistry that focuses on the diagnosis, treatment, and management of sleep-related breathing disorders, particularly obstructive sleep apnea (OSA). Dentists trained in dental sleep medicine work collaboratively with sleep physicians to provide oral appliance therapy as an alternative treatment to continuous positive airway pressure (CPAP) machines. These oral appliances are custom-fit devices designed to help keep the airway open during sleep, improving breathing and reducing the severity of sleep apnea symptoms.           

Dental Sleep Medicine Market Dynamics

Drivers

• Increasing Awareness Diagnosis 

The growing awareness of sleep disorders, particularly obstructive sleep apnea (OSA), has significantly bolstered the demand for dental sleep medicine solutions. As more individuals recognize the symptoms and risks associated with untreated OSA, there is a heightened interest in seeking effective treatment options beyond traditional methods like CPAP machines. This increased awareness not only drives patient demand but also encourages healthcare providers to integrate dental sleep medicine into their diagnostic and treatment protocols, thereby expanding the market for oral appliances and related services.      

• Non-Invasive Treatment Options      

Oral appliances represent a pivotal advancement in non-invasive treatment options for sleep-related breathing disorders, offering a viable alternative to dental sleep medicine appliances. These devices are favored by patients seeking more comfortable and user-friendly solutions for managing conditions such as OSA. Unlike CPAP, which requires wearing a mask during sleep and can cause discomfort or claustrophobia, oral appliances are custom-fit devices that reposition the jaw and tongue to maintain an open airway. This comfort and ease of use contribute to higher patient compliance rates, thereby enhancing the appeal and market acceptance of dental sleep medicine as a whole.

Opportunities

• Collaboration between Dental and Sleep Medicine Specialists   

Collaborative efforts between dental professionals and sleep physicians are instrumental in advancing the field of dental sleep medicine. By pooling their expertise, these specialists can leverage combined diagnostic tools and treatment approaches to provide comprehensive care for patients with sleep disorders. This collaboration not only enhances diagnostic accuracy but also improves the overall management of conditions like OSA through tailored treatment plans that may include oral appliances. Such integrated care models are critical for optimizing patient outcomes and expanding the scope of dental sleep medicine.        

• Increasing Healthcare Expenditure     

The rising global healthcare expenditure, coupled with expanded insurance coverage for dental sleep medicine treatments, is a significant driver of market growth. As healthcare systems allocate more resources towards preventative and specialized care, there is greater accessibility to oral appliances and related services for patients with sleep-related breathing disorders. This financial support not only increases patient affordability but also encourages healthcare providers to invest in advanced technologies and infrastructure necessary for delivering high-quality dental sleep medicine solutions, creating new market opportunities. 

Restraints/Challenges

• Limited Reimbursement Policies

Inconsistent reimbursement policies and limited coverage for dental sleep medicine treatments in certain regions pose challenges to market growth. These policies may deter healthcare providers from offering comprehensive oral appliance therapy or hinder patient access to affordable treatment options. Addressing these reimbursement issues requires advocacy efforts to standardize coverage guidelines and highlight the cost-effectiveness of dental sleep medicine in managing sleep disorders like OSA. 

• Patient Compliance Issues

Challenges related to patient compliance with oral appliance therapy represent another barrier to market growth within dental sleep medicine. Despite the comfort and convenience offered by oral appliances compared to CPAP machines, some patients may experience initial discomfort or difficulty adjusting to the devices. This could lead to lower adoption rates and suboptimal treatment outcomes if compliance issues are not effectively addressed and present challenges for the market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In October 2023, Apnimed, Inc., a clinical-stage pharmaceutical company specializing in oral pharmacologic therapies for obstructive sleep apnea (OSA) and other sleep disorders, disclosed a new collaboration. They have entered into a joint venture with Shionogi & Co., Ltd., a prominent global pharmaceutical company headquartered in Japan. This partnership aims to pioneer innovative pharmacologic treatments for obstructive sleep apnea (OSA) and other sleep-related conditions
• In June 2023, Torch Dental, a prominent platform for dental procurement, ordering, and expenditure management, partnered with the American Academy of Dental Sleep Medicine (AADSM). This collaboration aims to provide unique advantages exclusively for AADSM members, marking a significant achievement as both entities merge their knowledge to enhance dental sleep medicine through innovative solutions, education, and practice management
• In December 2022, New West Dental Lab introduced the EndSnorZ Sleep Appliance, expanding its range of mandibular advancement devices (MADs). This new addition offers dentists a customizable, patient-specific solution using 3D-printing technology. The appliance is designed to treat snoring and obstructive sleep apnea (OSA), featuring adjustability in increments of 0.5 mm over a range of 10 mm, providing precise and tailored treatment options for patients

Dental Sleep Medicine Market Scope

The market is segmented on the basis of type, treatment & diagnostics, age group, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Diagnostic
• Treatment

Treatment & Diagnostics

• Positive Airway Pressure (PAP) Therapy
• Oral and Nasal Devices
• Airway Systems
• Other Devices
• Drugs
• Surgery
• Polysomnography and Polygraphy
• Oximetry and Actigraph

Age Group

• Pediatric
• Adult
• Geriatric

End User

• Hospitals
• Sleep Laboratories
• Home
• Others

Dental Sleep Medicine Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, type, treatment & diagnostics, age group, and end user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to favorable reimbursement policies, extensive awareness regarding dental sleep medicine, and a robust presence of manufacturers, suppliers, and distributors, particularly in the U.S..

Asia-Pacific is expected to witness significant growth during the forecast period due to increased healthcare spending from both governmental and private sectors, coupled with a rising number of patients seeking treatment for sleep disorders like insomnia and sleep apnea. In addition, the expanding medical tourism sector in Asia Pacific is anticipated to further stimulate demand for dental devices in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Dental Sleep Medicine Market Share Analysis

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• Koninklijke Philips NV(네덜란드)
• ResMed(호주)
• Fisher & Paykel Healthcare Limited(뉴질랜드)
• DeVilbiss Healthcare LLC(미국)
• 치료 의학 (미국)
• 에이펙스 치과 수면 연구소(미국)
• BMC Medical Co., Ltd. (중국)
• BD(Becton, Dickinson and Company) (미국)
• Cadwell Industries Inc. (미국)
• 인바케어 코퍼레이션(미국)
• 컴퓨메딕스 리미티드(호주)
• Braebon Medical Corporation (캐나다)
• 제너럴 일렉트릭(미국)
• SomnoMed (호주)
• 헨리 샤인 주식회사(미국)

SKU-60890